GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BLIS Technologies Ltd (NZSE:BLT) » Definitions » PB Ratio

BLIS Technologies (NZSE:BLT) PB Ratio : 2.00 (As of May. 23, 2024)


View and export this data going back to 2001. Start your Free Trial

What is BLIS Technologies PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-23), BLIS Technologies's share price is NZ$0.016. BLIS Technologies's Book Value per Share for the quarter that ended in Sep. 2023 was NZ$0.01. Hence, BLIS Technologies's PB Ratio of today is 2.00.

The historical rank and industry rank for BLIS Technologies's PB Ratio or its related term are showing as below:

NZSE:BLT' s PB Ratio Range Over the Past 10 Years
Min: 1.67   Med: 6.67   Max: 23.33
Current: 2

During the past 13 years, BLIS Technologies's highest PB Ratio was 23.33. The lowest was 1.67. And the median was 6.67.

NZSE:BLT's PB Ratio is ranked better than
58.42% of 1313 companies
in the Biotechnology industry
Industry Median: 2.54 vs NZSE:BLT: 2.00

During the past 3 years, the average Book Value Per Share Growth Rate was 21.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 29.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 5.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of BLIS Technologies was 49.40% per year. The lowest was -44.20% per year. And the median was -9.10% per year.

Back to Basics: PB Ratio


BLIS Technologies PB Ratio Historical Data

The historical data trend for BLIS Technologies's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BLIS Technologies PB Ratio Chart

BLIS Technologies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.67 12.00 13.20 4.10 3.22

BLIS Technologies Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.50 4.10 4.00 3.22 2.88

Competitive Comparison of BLIS Technologies's PB Ratio

For the Biotechnology subindustry, BLIS Technologies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BLIS Technologies's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BLIS Technologies's PB Ratio distribution charts can be found below:

* The bar in red indicates where BLIS Technologies's PB Ratio falls into.



BLIS Technologies PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

BLIS Technologies's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Sep. 2023)
=0.016/0.008
=2.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


BLIS Technologies  (NZSE:BLT) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


BLIS Technologies PB Ratio Related Terms

Thank you for viewing the detailed overview of BLIS Technologies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


BLIS Technologies (NZSE:BLT) Business Description

Traded in Other Exchanges
N/A
Address
442 Moray Place, Ground Floor, Dunedin, OTA, NZL, 9016
BLIS Technologies Ltd is engaged in developing oral probiotics. The company markets two strains of probiotic bacteria BLIS K12, BLIS Q24, and BLIS M18 both of which occur naturally in the oral cavity. Its product portfolio consists of probiotic serum, Teeth and gums lozenge, fresh breath lozenge, and immune lozenge. Geographically, the company derives a majority of its revenue from EMEA (Europe, the Middle East, and Africa).

BLIS Technologies (NZSE:BLT) Headlines

From GuruFocus

John Rogers Comments on Blount Intl Inc.

By Holly LaFon Holly LaFon 01-22-2016

John Rogers Increases Stake in Blount International

By Tiziano Frateschi Tiziano Frateschi 04-13-2015

Ariel Fund Quarterly Commentary From John Rogers

By Holly LaFon Holly LaFon 01-21-2016

Bill Nygren's Oakmark Comments on Blount International

By Holly LaFon Holly LaFon 07-10-2012

Jean-Marie Eveillard Sells More Blount International

By Holly LaFon Holly LaFon 10-09-2012

Olstein Strategic Opportunities Fund 2014 Investor Letter

By Canadian Value Canadian Value 04-01-2015

John Rogers' Recent Trades

By Tiziano Frateschi Tiziano Frateschi 04-06-2016